Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.

Literature DB >> 16186683

Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.

Vandana Jain¹, Anu Maheshwari, Sheffali Gulati, Madhulika Kabra, Veena Kalra.

Abstract

Myelofibrosis with myeloid metaplasia is defined as a myeloproliferative disorder characterized by leukoerythroblastosis, tear drop erythrocytes, extramedullary hematopoesis and varying degree of myelofibrosis. It may be idiopathic or secondary to a large number of conditions. Here is a rare case of myelofibrosis occurring in a patient with juvenile rheumatoid arthritis.

Entities: Disease Species

Mesh：

Substances：

Year: 2005 PMID： 16186683 DOI： 10.1007/bf02734153

Source DB: PubMed Journal: Indian J Pediatr ISSN： 0019-5456 Impact factor: 1.967

15 in total

Review 1. Spontaneous remission of juvenile idiopathic myelofibrosis.

Authors: A Sah; A Minford; L A Parapia
Journal: Br J Haematol Date: 2001-03 Impact factor: 6.998

2. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation.

Authors: P Guardiola; H Esperou; D Cazals-Hatem; N Ifrah; J P Jouet; A Buzyn; L Sutton; N Gratecos; H Tilly; B Lioure; E Gluckman
Journal: Br J Haematol Date: 1997-09 Impact factor: 6.998

3. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts.

Authors: A Kimura; O Katoh; H Hyodo; A Kuramoto
Journal: Br J Haematol Date: 1989-08 Impact factor: 6.998

4. A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Authors: R A Mesa; A Tefferi; M A Elliott; H C Hoagland; T G Call; G S Schroeder; S Y Yoon; C Y Li; L A Gray; S Margolin; C C Hook
Journal: Br J Haematol Date: 2001-07 Impact factor: 6.998

Review 1. An immune dysregulation in MPN.

Authors: Giovanni Barosi
Journal: Curr Hematol Malig Rep Date: 2014-12 Impact factor: 3.952

2. Myelofibrosis-related arthritis successfully treated with hydroxyurea.

Authors: Xavier Guillot; Marius Moldovan; Claire Vidon; Daniel Wendling
Journal: Case Rep Rheumatol Date: 2014-04-10

2 in total

Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.

Review 1. Spontaneous remission of juvenile idiopathic myelofibrosis.

2. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation.

3. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts.

4. A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Review 5. Myelofibrosis with myeloid metaplasia.

6. Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

7. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.

8. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus.

9. Idiopathic myelofibrosis in children.

10. Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy.

Review 1. An immune dysregulation in MPN.

2. Myelofibrosis-related arthritis successfully treated with hydroxyurea.